Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patients

Published: Feb 1, 2023   |   Author: Gabriella True   |   Category: Blog, Research   |   No Comments

Susanne Bejerot, Sofia Sigra Stein, Elisabet Welin, Daniel Eklund, Ulrika Hylén, Mats B. Humble, Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies […]

Read more

Association of Primary Immunodeficiencies in Parents With Psychiatric Disorders and Suicidal Behavior in Their Offspring

Published: Feb 1, 2023   |   Author: Gabriella True   |   Category: Blog, Research   |   No Comments

Isung J, Isomura K, Williams K, et al. Association of Primary Immunodeficiencies in Parents With Psychiatric Disorders and Suicidal Behavior in Their Offspring. JAMA Psychiatry. 2023;80(4):323–330. doi:10.1001/jamapsychiatry.2022.4786 Cohort study (4,294,169 […]

Read more

The FGF/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: likely intersectionality with other neurological conditions

Published: Jan 17, 2023   |   Author: Gabriella True   |   Category: Blog, Research   |   Tags: ,   |   No Comments

Parthasarathy G, Pattison MB, Midkiff CC. The FGF/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: likely intersectionality with other neurological conditions. J Neuroinflammation. 2023 Jan 17;20(1):10. doi: 10.1186/s12974-022-02681-x. PMID: […]

Read more